Company Filing History:
1 out of 27 
1 out of 712 
2 out of 832,812 Years Active: 2002-2006
Title: The Innovations of Karl Steven LaForge
Introduction
Karl Steven LaForge is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the area of opioid receptors. With a total of 4 patents to his name, LaForge's work has implications for pain management and addiction treatment.
Latest Patents
LaForge's latest patents include groundbreaking research on alleles of the human mu opioid receptor. His work provides variant alleles of a gene encoding a mu opioid receptor, along with cloning vectors for replicating these alleles. He has also developed methods for diagnosing susceptibility to pain and addictive diseases. Additionally, his patents cover diagnostic methods for various disorders, including infertility and immune response issues. Another significant patent involves variants of the human kappa opioid receptor gene, which also includes cloning and expressing vectors for producing variant kappa opioid receptors.
Career Highlights
Throughout his career, LaForge has worked with prestigious institutions, including The Rockefeller University. His research has contributed to a deeper understanding of opioid receptors and their role in pain management and addiction.
Collaborations
LaForge has collaborated with notable colleagues such as Mary Jeanne Kreek and Lei Yu. Their combined expertise has further advanced the research in opioid receptor studies.
Conclusion
Karl Steven LaForge's innovative work in the field of opioid receptors has paved the way for advancements in medical diagnostics and treatment options. His contributions continue to impact the understanding of pain and addiction.